186 related articles for article (PubMed ID: 35360718)
1. Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients.
Topi G; Ghatak S; Satapathy SR; Ehrnström R; Lydrup ML; Sjölander A
Front Med (Lausanne); 2022; 9():739620. PubMed ID: 35360718
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
Tan W; Li Q; Chen K; Su F; Song E; Gong C
Oncotarget; 2016 Mar; 7(9):10373-85. PubMed ID: 26863572
[TBL] [Abstract][Full Text] [Related]
3. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer: A meta-analysis.
Zhang D; Ku J; Yi Y; Zhang J; Liu R; Tang N
Medicine (Baltimore); 2019 Nov; 98(46):e17954. PubMed ID: 31725654
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor beta in human colorectal cancer.
Xie LQ; Yu JP; Luo HS
World J Gastroenterol; 2004 Jan; 10(2):214-7. PubMed ID: 14716825
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer.
Nüssler NC; Reinbacher K; Shanny N; Schirmeier A; Glanemann M; Neuhaus P; Nussler AK; Kirschner M
Gend Med; 2008 Sep; 5(3):209-17. PubMed ID: 18727987
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
7. Expression of oestrogen receptor β and prognosis of colorectal cancer.
Rudolph A; Toth C; Hoffmeister M; Roth W; Herpel E; Jansen L; Marx A; Brenner H; Chang-Claude J
Br J Cancer; 2012 Aug; 107(5):831-9. PubMed ID: 22828608
[TBL] [Abstract][Full Text] [Related]
8. Decreased ERβ expression and high cyclin D1 expression may predict early CRC recurrence in high-risk Duke's B and Duke's C stage.
Babic A; Miladinovic N; Milin Lazovic J; Milenkovic S
J BUON; 2021; 26(2):536-543. PubMed ID: 34077003
[TBL] [Abstract][Full Text] [Related]
9. Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer.
Topi G; Ehrnström R; Jirström K; Palmquist I; Lydrup ML; Sjölander A
Eur J Cancer; 2017 Sep; 83():279-289. PubMed ID: 28763692
[TBL] [Abstract][Full Text] [Related]
10. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Estrogen Receptor β Isoform With Correlation of Estrogen Receptor α Among Sudanese Breast Cancer Patients.
Shalabi MG; Abbas AM; Mills J; Kheirelseid MA; Elderdery AY
Breast Cancer (Auckl); 2021; 15():1178223421998354. PubMed ID: 33716507
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysis.
Niv Y
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1438-42. PubMed ID: 26367493
[TBL] [Abstract][Full Text] [Related]
16. Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model.
Topi G; Satapathy SR; Dash P; Fred Mehrabi S; Ehrnström R; Olsson R; Lydrup ML; Sjölander A
J Pathol; 2020 Jul; 251(3):297-309. PubMed ID: 32333795
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.
De Stefano I; Zannoni GF; Prisco MG; Fagotti A; Tortorella L; Vizzielli G; Mencaglia L; Scambia G; Gallo D
Gynecol Oncol; 2011 Sep; 122(3):573-9. PubMed ID: 21665249
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.
Stabile LP; Dacic S; Land SR; Lenzner DE; Dhir R; Acquafondata M; Landreneau RJ; Grandis JR; Siegfried JM
Clin Cancer Res; 2011 Jan; 17(1):154-64. PubMed ID: 21062926
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
Motomura K; Ishitobi M; Komoike Y; Koyama H; Nagase H; Inaji H; Noguchi S
Oncology; 2010; 79(1-2):55-61. PubMed ID: 21071990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
